The purpose of the Bioinformatics Facility is to provide investigators at the Fox Chase Cancer Center (FCCC) with state-of-the-art tools and expertise for handling genomics and functional genomics data. The Facility staff include a range of expertise, with Ph.D. level scientists trained in biochemistry, biophysics, and physics providing guidance in data storage and analysis for genetic, genomic, phylogenomic, flow cytometry, and proteomic data. In addition, substantial expertise is maintained in software design, development, and deployment, allowing the Facility to quickly respond to the changing needs of Fox Chase research staff. The Facility maintains and supports bioinformatics software for sequence analysis, secondary structure prediction, imaging and image serving, mathematical analysis, high throughput data analysis, data management (through laboratory information management systems), annotation, and data querying. In addition, the staff assists the investigators directly in advanced analysis using Web resources, including phylogenomic footprinting, protein-protein interaction searches, multi-species pathway analysis, and specialized analyses as needed. Facility staff have expertise in biochemistry, data analysis, mathematical modeling, scientific databases, Web interface design, workflow analysis, and statistics. Development expertise is focused in object oriented design and Java programming, although extensive use of Perl and C is made as well. The Facility was rated """"""""Outstanding to Excellent"""""""" in the last CCSG review. Increasing use of the Facility by 57 Principal Investigators from all three divisions has required the addition of eight staff members since the last review. Ninety-six percent (96%) of Facility use is by peer-reviewed funded investigators at Fox Chase. In response to the needs of these investigators, nine systems have been developed by the Facility since the last review. The Facility has increased interactions between peer-reviewed funded investigators with these new systems.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-47
Application #
7881790
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
47
Fiscal Year
2009
Total Cost
$539,010
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Nikonova, Anna S; Deneka, Alexander Y; Kiseleva, Anna A et al. (2018) Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). FASEB J 32:2735-2746
Nacson, Joseph; Krais, John J; Bernhardy, Andrea J et al. (2018) BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep 25:1384
Di Marcantonio, Daniela; Martinez, Esteban; Sidoli, Simone et al. (2018) Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia. Clin Cancer Res 24:608-618
Singh, Tanu; Lee, Eric H; Hartman, Tiffiney R et al. (2018) Opposing Action of Hedgehog and Insulin Signaling Balances Proliferation and Autophagy to Determine Follicle Stem Cell Lifespan. Dev Cell 46:720-734.e6
Gabbasov, Rashid; Xiao, Fang; Howe, Caitlin G et al. (2018) NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice. Oncogene 37:4854-4870
Nacson, Joseph; Krais, John J; Bernhardy, Andrea J et al. (2018) BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep 24:3513-3527.e7
Fahl, Shawn P; Coffey, Francis; Kain, Lisa et al. (2018) Role of a selecting ligand in shaping the murine ??-TCR repertoire. Proc Natl Acad Sci U S A 115:1889-1894
Jones, Caitlin E; Hammer, Anisha M; Cho, YouJin et al. (2018) Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia 21:132-145
Shaikh, Talha; Wang, Lora S; Egleston, Brian et al. (2018) Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol 41:59-64
Campbell, Kerry S; Cohen, Adam D; Pazina, Tatiana (2018) Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Front Immunol 9:2551

Showing the most recent 10 out of 1280 publications